ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EX05 | B | Regorafenib - 40mg | 10007 | 13819/1 | STIVARGA | 40mg | 3 x 28 | Tablet, film coated | Oral | Droguerie R. Pharaon & Fils S.A.L. | Bayer AG | Germany | 248,392,730 L.L | 2.44 | E2 | Bayer (Schweiz) AG | Switzerland | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EX05 | B | Regorafenib - 40mg | 10007/388 | 13819/1 | STIVARGA | 40mg | 3 x 28 | Tablet, film coated | Oral | Droguerie R. Pharaon & Fils S.A.L. | Bayer AG | Germany | L.L | 2.44 | E2 | Bayer (Schweiz) AG | Switzerland | 05/02/20 |